Organ Procurement Overview and Updates for Payers, Providers, and Patients

In the world of healthcare, the regulation of the organ procurement industry has become a topic of interest among various stakeholders, including payers, providers, and patients. Recently, there has been congressional attention on this vital aspect of the healthcare system, prompting discussions on the latest updates and developments in organ procurement.

Rachel Park, a senior counsel at Crowell & Moring’s Washington, D.C. office, brings valuable experience and insights to the table. With a background that includes 24 years of service at the U.S. Department of Health and Human Services, Rachel is well-versed in a wide array of healthcare matters. Her expertise ranges from Medicare and Medicaid reimbursement to managed care litigation and health care fraud investigations and oversight. Lisa Umans, a partner at Crowell & Moring’s New York office, also contributes her expertise to the discussion. With a focus on regulatory enforcement and financial services, Lisa represents large institutional clients and individuals in federal and state regulatory and criminal investigations.

The regulation of organ procurement organizations (OPO) has been a significant point of focus in recent times. The Centers for Medicare and Medicaid Services (CMS) has proposed a rule governing OPO oversight that will have implications for ongoing OPO participation. This regulation is crucial in ensuring the efficiency and reliability of organ procurement processes, ultimately impacting patient outcomes and the healthcare system as a whole.

Crowell & Moring’s health care podcast, Payers, Providers, and Patients – Oh My!, delves into the legal and regulatory issues affecting healthcare entities’ in-house counsel, executives, and investors. In a recent episode, hosts Megan Beaver and Savanna Williams engage in a conversation with Rachel Park and Lisa Umans, shedding light on the latest updates in the organ procurement industry. From discussing recent congressional interests to exploring CMS regulations, the podcast offers valuable insights into the current landscape of organ procurement.

The intricate nature of organ procurement underscores the importance of regulatory oversight and adherence to standards. By ensuring that organ procurement organizations operate effectively and transparently, healthcare stakeholders can uphold the integrity of the system and prioritize patient care. As the industry continues to evolve, discussions and dialogues around regulatory updates and best practices will be essential in driving positive change and improving outcomes for patients in need of organ transplants.